Kevin McKernan

They have figured out how to get a state-by-state initiative to get medical cannabis to patients. We should be thinking about the same things for other generic drugs that they're trying to take from the population or tie up in pharmaceutical red tape, if you will.

They have figured out how to get a state-by-state initiative to get medical cannabis to patients. We should be thinking about the same things for other generic drugs that they're trying to take from the population or tie up in pharmaceutical red tape, if you will.

They have figured out how to get a state-by-state initiative to get medical cannabis to patients. We should be thinking about the same things for other generic drugs that they're trying to take from the population or tie up in pharmaceutical red tape, if you will.

And physicians that are good at that are also very open to psilocybin and into red light therapy and into cold dipping and all of these alternatives to keep you out of the hospital. The cheap stuff. The cheap stuff that no pharmaceutical wants to fund and that you can do by yourself.

And physicians that are good at that are also very open to psilocybin and into red light therapy and into cold dipping and all of these alternatives to keep you out of the hospital. The cheap stuff. The cheap stuff that no pharmaceutical wants to fund and that you can do by yourself.

And physicians that are good at that are also very open to psilocybin and into red light therapy and into cold dipping and all of these alternatives to keep you out of the hospital. The cheap stuff. The cheap stuff that no pharmaceutical wants to fund and that you can do by yourself.

Basically, the patient-physician relationship is what we need to garner, and no one else should be in that but you and the physician. And these physicians are trying to develop medicines that keep that relationship closer rather than having a third party in the middle of it all.

Basically, the patient-physician relationship is what we need to garner, and no one else should be in that but you and the physician. And these physicians are trying to develop medicines that keep that relationship closer rather than having a third party in the middle of it all.

Basically, the patient-physician relationship is what we need to garner, and no one else should be in that but you and the physician. And these physicians are trying to develop medicines that keep that relationship closer rather than having a third party in the middle of it all.

So it's a great group of people because you'll get physicians or get nurses, you'll get growers, you'll get analytical chemists who know how to do the safety testing.

So it's a great group of people because you'll get physicians or get nurses, you'll get growers, you'll get analytical chemists who know how to do the safety testing.

So it's a great group of people because you'll get physicians or get nurses, you'll get growers, you'll get analytical chemists who know how to do the safety testing.

And we tend to get a lot of regulators and politicians that come down as well just to see, like, how do we do this safely in different jurisdictions and not make the same mistakes as the people who who cut the first first stones on this, if you will.

And we tend to get a lot of regulators and politicians that come down as well just to see, like, how do we do this safely in different jurisdictions and not make the same mistakes as the people who who cut the first first stones on this, if you will.

And we tend to get a lot of regulators and politicians that come down as well just to see, like, how do we do this safely in different jurisdictions and not make the same mistakes as the people who who cut the first first stones on this, if you will.

Yes. Dr. William Mackis was just presenting on this, and they're using fenbenon ivermectin. Really? Yes. For cancer. Yes. Yeah, I know. And the exact mechanism, I'll leave it for him to describe. I haven't quite figured out how that's behaving. And then there's probably some relevance if they are in fact spike protein driven and you have evidence of spike being there.

Yes. Dr. William Mackis was just presenting on this, and they're using fenbenon ivermectin. Really? Yes. For cancer. Yes. Yeah, I know. And the exact mechanism, I'll leave it for him to describe. I haven't quite figured out how that's behaving. And then there's probably some relevance if they are in fact spike protein driven and you have evidence of spike being there.

Yes. Dr. William Mackis was just presenting on this, and they're using fenbenon ivermectin. Really? Yes. For cancer. Yes. Yeah, I know. And the exact mechanism, I'll leave it for him to describe. I haven't quite figured out how that's behaving. And then there's probably some relevance if they are in fact spike protein driven and you have evidence of spike being there.

I saw McCullough present on – they're building some tests to test for spike protein. We're working with some people as well that we have DNA tests to look for the DNA floating around. We don't look for the protein, but those are tests that people can potentially run. So they're building the diagnostic tools to search for, all right, is this turbo cancer related to the vaccine? Yeah.

I saw McCullough present on – they're building some tests to test for spike protein. We're working with some people as well that we have DNA tests to look for the DNA floating around. We don't look for the protein, but those are tests that people can potentially run. So they're building the diagnostic tools to search for, all right, is this turbo cancer related to the vaccine? Yeah.